Immix Biopharma (IMMX) Earnings Date & Reports

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IMMX is expected to report earnings to fall 2.17% to -17 cents per share on September 02

Immix Biopharma IMMX Stock Earnings Reports

Q2'26

Est.

$-0.18

Q1'26

Beat

by $0.03

Q4'25

Missed

by $0.08

Q3'25

Missed

by $0.08

Q2'25

Missed

by $0.01

The last earnings report on May 07 showed earnings per share of -18 cents, beating the estimate of -21 cents. With 559.26K shares outstanding, the current market capitalization sits at 669.54M.

View a ticker or compare two or three

Compare

IMMX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for IMMX